Clinic
Bloom New Mexico LLC
Bloom New Mexico LLC was paid $7.92M by Medicaid between May 2020 and Dec 2024, across 36 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoBLOOM NEW MEXICO LLC
FARMINGTON, NM 87402
FARMINGTON, NM 87402
33aNPI1750942207assigned 06/25/2019
33bProvider typeUrgent Care Clinic/Center
28Total paid$7.92M
24GClaims172,827
24DCodes billed36
24AFirst – last monthMay 2020 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in New Mexico
Rank by total paid#3 of 26
Median peer was paid$1.29M
This provider vs. median6.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 44,828 | $1.74M | |
| 2021 | 75,939 | $3.29M | |
| 2022 | 30,749 | $1.21M | |
| 2023 | 8,930 | $630K | |
| 2024incomplete | 12,381 | $1.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 15,869 | 14,394 | $1.56M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 19% | 11,992 | 10,319 | $1.52M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 16% | 28,461 | 24,451 | $1.27M |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 14% | 14,999 | 12,220 | $1.12M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.7% | 9,455 | 8,766 | $689K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 7.8% | 6,924 | 6,304 | $614K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5.1% | 14,840 | 12,067 | $403K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.4% | 18,150 | 8,488 | $265K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.5% | 10,524 | 9,174 | $199K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 7,825 | 7,319 | $116K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,623 | 1,510 | $58K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 933 | 731 | $28K |
24 more codes
| 99051 | <1% | 4,154 | $21K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,228 | $10K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 273 | $10K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 522 | $8K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 494 | $7K |
| 90686 | <1% | 517 | $5K | |
| 99072 | <1% | 12,121 | $5K | |
| 99000 | <1% | 5,140 | $3K | |
| 90674 | <1% | 65 | $2K | |
| 86769 | <1% | 215 | $2K | |
| 81003 | <1% | 841 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 49 | $1K |
| 87807 | <1% | 81 | $1K | |
| 81025 | <1% | 118 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 17 | $779.62 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 45 | $404.40 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 109 | $388.12 |
| 90688 | <1% | 14 | $215.20 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 143 | $151.37 |
| 82962 | <1% | 46 | $134.63 | |
| S9083 | Global fee urgent care centers | <1% | 1,742 | $124.11 |
| 36416 | <1% | 249 | $75.53 | |
| 81002 | <1% | 32 | $68.22 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 17 | $1.97 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSMITH, SPENCER (CEO)
| Provider | Location | Paid |
|---|---|---|
| Bloom Idaho LLC | Garden City, ID | $1.29M |
| Bloom Colorado LLC | Cortez, CO | $547K |
| Benchmark Dental, PC | Riverton, WY | $259K |
| Bloom Idaho LLC | Nampa, ID | $77K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.